Ground-Breaking News on Lung Cancer Treatment Using CyberKnife

Share Article

The CyberKnife boasts totally non-invasive lung cancer treatment with Accuray's Xsight™ Lung Tracking System.

said James Schwade, M.D., executive director of the CyberKnife Centers of Miami and Palm Beach.

The CyberKnife Center of Miami has added the Xsight Lung Tracking System to its arsenal of cancer tumor killing tools. The Xsight Lung Tracking System allows for totally non-invasive lung cancer treatment by implementing "fiducialess" radiotherapy. Now, an alternative to placing a gold seed marker for tracking purposes, Xsight Lung Tracking, uses an exceptional radiation dose of calculation algorithm to track the tumor while treating it.

Stereotactical radiotherapy utilizing the CyberKnife robot has gained widespread acceptance for its ability to target and administer radiation to tumors or lesions in patients that are deemed inoperable using conventional methods. The innovative system of the robotic arm delivering a precisely targeted large dose of radiation to a very small area has proven to be incomparably accurate for targeting treatment areas without damaging the healthy tissue surrounding it. Another revolutionary tool related to the administration of radiosurgery, the Xsight™ Lung Tracking System, a development of international radiosurgery leader Accuracy Incorporated, strengthens the CyberKnife's ability to administer radiation with supreme accuracy.

The CyberKnife & Xsight™ Lung Tracking System: a Powerful Combination

The CyberKnife system has so far been used in the nonsurgical treatment of thousands of patients across the globe. The advanced method treats difficult to reach areas such as the brain, organs and spinal cord, completely eliminating lesions and tumors without making a single incision or requiring the use of anesthesia. We have seen great success using Xsight Lung to treat lung cancer non-invasively because of its ability to lock onto and deliver radiation to the tumor while minimizing damage to healthy tissue," said James Schwade, M.D., executive director of the CyberKnife Centers of Miami and Palm Beach. "The CyberKnife System with Xsight Lung allows us to break down the barriers to lung cancer treatment. We are now able to give new hope to patients -- such as the elderly and those considered medically or surgically inoperable -- who have used to have no other option."

Working seamlessly with Accuray's CyberKnife System and Synchrony® Respiratory Tracking System, Xsight Lung is the only system that uses the body's internal anatomy to directly track targets with radiosurgical accuracy. It delivers the ultimate in soft tissue tracking by using the actual image intensity of the lung tumor to target the beam, therefore eliminating the need for external frames or implanted fiducials in most cases."

Patients who receive the treatment require no recovery time and experience no pain related to the treatment. This procedure can cost up to 45% less than typical radiation therapy treatments and is a viable alternative for patients whose conditions have been labeled as inoperable due to location, severity, or other factors.

CyberKnife - Non Surgical procedure for treatment of Cancer.

The CyberKnife Center of Miami
The CyberKnife Center of Miami provides radiosurgery treatments to eligible patients who may have otherwise had very little hope. Dr. James G. Schwade, Executive Director, FACRO, FACR has over 30 years experience in radiation oncology and treating patients with the CyberKnife utilizing stereotactical radiotherapy, and works with a team of well trained, experienced medical professionals throughout the world. One can visit the center's website online, and obtain more detailed information about the procedure, eligibility for candidates or get answers to any other questions they may have.

For more information about the CyberKnife Center of Miami, or the revolutionary CyberKnife system, please visit http://www.cyberknifemiami.com. Also visit our Cyber Notes

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Susan Nefzger

James Schwade, M.D.,
Visit website